Effects of N-acetyl Cysteine on Major Cardiac and Cerebral Events in Patients Undergoing Primary Percutaneous Coronary Intervention Who Have Moderate to High Risk For Contrast Induced Nephropathy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Myocardial infarction; Stroke
- Focus Therapeutic Use
- Acronyms EASE-PRM-PCI
- 05 Sep 2021 Biomarkers information updated
- 03 Jul 2013 New trial record